Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TKT | P29401 | 5/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL30565607 | 0.98 | LMNA (0.59) | LMNAKDM4EALDH1A1CYP1A2TSHR | |
| SCHEMBL12346332 | 0.81 | LMNA (0.63) | LMNAKDM4EALDH1A1CYP1A2TSHR | |
| SCHEMBL478879 | 0.81 | LMNA (0.63) | LMNAKDM4EALDH1A1CYP1A2TSHR | |
| SCHEMBL23748348 | 0.81 | LMNA (0.63) | LMNAKDM4EALDH1A1CYP1A2TSHR | |
| SCHEMBL29895545 | 0.81 | LMNA (0.63) | LMNAKDM4EALDH1A1CYP1A2TSHR | |
| SCHEMBL16015176 | 0.79 | LMNA (0.61) | LMNAKDM4EALDH1A1CYP1A2TSHR | |
| Hydrochloric Acid SCHEMBL479404 | 0.79 | LMNA (0.61) | LMNAKDM4EALDH1A1CYP1A2TSHR | |
| SCHEMBL23973989 | 0.79 | LMNA (0.61) | LMNAKDM4EALDH1A1CYP1A2TSHR | |
| SCHEMBL4358570 | 0.79 | LMNA (0.61) | LMNAKDM4EALDH1A1CYP1A2TSHR | |
| SCHEMBL20310245 | 0.79 | LMNA (0.61) | LMNAKDM4EALDH1A1CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11969002-B2 | Savoury and mouthfulness taste enhancers | LUCTA, S.A. (ES) | 2024-04-30 | — | — | US | disclosed |
| EP-3864012-B1 | SAVOURY AND MOUTHFULNESS TASTE ENHANCERS | LUCTA S A (ES) | 2023-09-13 | — | — | EP | disclosed |
| US-20210337850-A1 | SAVOURY AND MOUTHFULNESS TASTE ENHANCERS | LUCTA, S.A. (ES) | 2021-11-04 | — | — | US | disclosed |
| EP-3864012-A1 | SAVOURY AND MOUTHFULNESS TASTE ENHANCERS | Lucta, S.A. (ES) | 2021-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210337850-A1 | SAVOURY AND MOUTHFULNESS TASTE ENHANCERS | KCNJ6, TAS1R1, TAS2R5 | LMNA 3556/4885KDM4E 699/4885ALDH1A1 1833/4885 |
| US-11969002-B2 | Savoury and mouthfulness taste enhancers | TAS1R1, KCNJ6, KCNJ5 | LMNA 3413/4885KDM4E 815/4885ALDH1A1 1527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.